Skip to main content
OpenTrials

Clinical trial condition

Paraneoplastic Syndromes

Explore clinical trials studying Paraneoplastic Syndromes. Study availability and eligibility vary by location and protocol.

344 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Paraneoplastic Syndromes trial results

Completed

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

NCT03759366

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Columbia, Missouri, United States
View Trial Details
Completed

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

NCT02965573

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Investigator Site 19 Irvine, California, United States
  • Investigator Site 17 Los Angeles, California, United States
  • Investigator Site 15 Tampa, Florida, United States
  • Investigator Site 16 Indianapolis, Indiana, United States
View all 19 locations
View Trial Details
Completed

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

NCT03920293

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Irvine, California, United States
View all 106 locations
View Trial Details

Related conditions